New Zealand has a widely dispersed population of 4.9 million.
There is a single paediatric cardiac centre. Maternity care provision for pregnant women is universally funded. The country has a well-developed screening programme for the antenatal detection of congenital cardiac anomalies. 6 Primary maternity care is provided by a Lead Maternity Carer (LMC). The majority of LMCs are midwives 7 who provide continuity of care in a partnership model from early pregnancy, through labour and birth, and up to 6 weeks post-partum. 8 Women have a choice of who provides their care (an LMC can be an obstetrician, a midwife or a General Practitioner) and where they birth.
Women with low-risk pregnancies can birth at home, in a primary maternity unit or in a secondary or tertiary facility. Following normal births in a secondary/tertiary hospital, women are often discharged to either home or primary maternity unit within a few hours of birth.
The context of care is therefore different to many other developed countries. For a quality improvement initiative to be successful, it must be adaptable to local needs. In view of this, a feasibility study of pulse oximetry screening was undertaken to identify local factors that should be considered in the design of a national screening strategy for New Zealand specifically in the context of good antenatal detection rates for CCHD. In addition, there was a need to consider the optimal timing of screening dependent on birthplace and age of the infant. Strategies were explored to limit the number of low oxygen saturation readings in the absence of underlying pathology.
| ME THODS
This study was a part of an intervention study exploring the feasibility of pulse oximetry screening at hospitals and primary maternity units affiliated with three of New Zealand's 20 health districts.
Screening was introduced at a metropolitan hospital and its neighbouring primary maternity unit (District A) in May 2016 followed by the introduction of screening at a regional level 1 and level 2 hospital (District B) in June 2016. Three primary maternity units from District C joined the study in November 2016. Data were collected up to 30 April 2018. District A's hospital is a quaternary referral centre where New Zealand's sole paediatric cardiac service is based.
Specialist paediatric services, including echocardiography, are available at District B's level 2 hospital. District C includes a tertiary referral hospital with specialist neonatal services. This hospital did not participate in the study, but several infants born at the hospital were screened if they transferred to a participating regional primary maternity unit for post-natal care. These units provide intrapartum and post-natal support and care to mothers and their newborns in the first few days following the birth. The neonatal team based at this tertiary centre provide advice and support to the primary facilities.
All pathologies identified as a result of pulse oximetry screening are reported as their early detection is potentially of benefit to the newborns, their families and the healthcare sector. However, test sensitivity, specificity and positive predictive value (PPV) were calculated for critical congenital cardiac defects only. The cardiac centre's databases were interrogated to identify all infants, not identified on antenatal ultrasound screening that underwent a cardiac catheter and/or surgical intervention. Mortality data were obtained from the New Zealand Ministry of Health's Mortality Collection and the Perinatal and Maternal Mortality Review Committee. We sought to identify cardiac-related deaths in infants born alive during the study period at any of the three participating districts. Deaths and cardiac interventions in the first 28 days after birth were identified to satisfy this definition commonly used to describe a 'critical' congenital cardiac defect. 9 Study guidelines and resources were developed prior to the introduction of screening. 10 Post-ductal oxygen saturations were measured on well newborn infants with a gestational age of ≥35 weeks.
The recommended time of entering the screening algorithm was between 2 and 24 hours after birth. Infants with a prenatal diagnosis of a congenital anomaly and other infants admitted to the Neonatal Intensive Care Unit (NICU) within 2 hours from birth were excluded from the study.
Identical hand-held pulse oximeters (Masimo; Radical SET, version 5 with reusable sensors) with an averaging time of 8 seconds were provided to all participating centres. Infants achieving an oxygen saturation of 95% or greater passed the test and required no further evaluation provided that they remained clinically well. Results below 90% warranted a referral to the nearest paediatric service for telephonic advice and/or clinical assessment. Saturations between 90% and 94% were regarded as an inconclusive result, and therefore, repeat testing had to be performed 1-2 hours later. Three consecutive results in the inconclusive range also warranted a paediatric referral. The relationship between oxygen saturation, infant activity and the infant's age at the time of the first screening test has been explored with the aim to assist in designing a screening strategy that will minimise saturation readings <95% in the context of no underlying pathology.
Pulse oximetry screening was performed by midwives or nurses.
Screeners received education making them aware that movement and crying can affect test accuracy and that earlier testing can result in lower oxygen saturation levels. However, no recommendations were made with regard to the ideal timing to conduct the test or Clinical records and investigations were retrospectively reviewed by a neonatologist to ascertain whether the diagnosis as reported on the CRF is appropriate. This provided a detailed report of time and resources invested into transferring, investigating and treating these infants.
| Statistical analysis
Median and range were used to describe continuous variables, and percentages were used for categorical variables. The chi-square test was used for comparisons between categorical variables and the Kruskal-Wallis test for comparisons between continuous variables.
Screening strategies were compared for the prespecified outcome by using multivariable logistic regression analysis and are presented as a probability of achieving a true-negative result. A P value <.05 was considered statistically significant. Data were analysed using statistical software (JMP, version 14.0; SAS Institute). Exclusion from analyses applied if key data fields were missing from a participant's CRF(s).
| RE SULTS
During the 24-month study period, pulse oximetry screening was performed on 16 644 of 27 172 (61%) eligible infants with the first test conducted at a median age of 7 hours (range 1-472). The timing of testing varied significantly among participating centres (Table 1) .
A higher proportion of inconclusive results requiring repeat testing were recorded for District A where infants entered the screening algorithm at a younger age (Table 1) . A pulse oximetry test prior to 4 hours of age resulted in a higher proportion of infants failing to achieve a saturation level of at least 95% compared with those undergoing testing more than 24 hours after birth (2.8% vs 1.9%; P = .005, Table 2 ). Infants that were unsettled or asleep at the time of testing were less likely to pass compared with awake and settled infants (P < .001 and P = .002, respectively). However, breastfeeding during the recording did not result in lower oxygen saturation levels ( infant screened prior to 4 hours of age to .99 (P < .001) when the test was performed after 24 hours on a settled infant ( Figure 1 ).
Forty-eight infants (0.3%) ultimately did not achieve oximetry screening targets; all but 7 (15%) were admitted to a newborn unit as a result (Table 3) . Eleven (23%) infants had to be transferred to a larger medical centre for assessment and investigations. The median distance travelled for an assessment was 43 km (range 1-80).
Critical congenital heart disease was detected in three infants.
A review of cardiac surgical data revealed a further two infants with a post-discharge diagnosis of d-loop transposition of the great arteries and one infant with atrial and ventricular septal defects that required intervention in the first 28 days after birth. Pulse oximetry screening was, however, not performed on these infants prior to discharge-they were therefore excluded from the test sensitivity calculation for the detection of CCHD. The sensitivity of pulse oximetry screening for the detection of CCHD in this study population was therefore 100%, the specificity 99.7% and the PPV 6.25%.
A further three infants had persistent pulmonary hypertension, and one newborn was diagnosed with supraventricular tachycardia.
Respiratory disease was responsible for the majority of positive screening results. There were 13 infants with congenital pneumonia, eight with transient tachypnoea of the newborn, four with meconium exposure and one with a pneumothorax. Three infants were diagnosed and treated for sepsis. One infant had an ongoing unexplained oxygen requirement (presumably related to respiratory pathology) and was discharged home on supplemental oxygen after 15 days. He remained on oxygen for a further 2 weeks after discharge (Table 3) .
No pathology could be identified in a further 11 (23%) infants who failed to reach saturation targets. Four (36%) of these infants were admitted to a neonatal unit for investigation and observation. The median (range) duration of admission was 1 day (0-2).
Seven infants failed the test as a result of saturation levels persistently in the 90%-94% range, and four had saturations below 90%. Testing was conducted at an early stage in the majority of these infants with the algorithm completed at a median age of 5 hours (range 3-36). A summary is provided of investigations performed on all infants who failed to reach oxygen saturation targets (Table 4 ).
| D ISCUSS I ON
This study of pulse oximetry screening was implemented in a setting with a high antenatal detection rate of congenital cardiac anomalies and with a largely midwifery-led maternity service. It demonstrated that regional-led screening programmes may result in heterogeneous practices that can affect the standard of the service provided.
A maternity system with early discharges necessitates that screening tests be conducted at an early age. This will result in a larger proportion of positive test results due to greater identification of pathology other than CCHD. In this study, several infants with significant respiratory or infectious pathology were identified prior to the onset of detectable clinical signs, likely preventing the discharge of those in need of medical intervention. place of birth. 10 Approximately 9% of women give birth at primary facilities 11 and will often remain at the facility for several days to receive post-natal care. Twenty-one per cent of the study cohort were screened at an age greater than the recommended time frame of 24 hours. This is mainly because many infants born at the nonparticipating tertiary centre were screened after transfer to a participating primary maternity unit. The place of birth is therefore an important factor determining the timing of testing. The feasibility of very early screening strategies has been investigated in settings with a high number of home births. The Dutch designed an algorithm where the first screening test was performed at approximately 1 hour after birth to fit in with the time midwives are routinely present. They reported a false-positive rate of 0.6%. 12 Cawsey et al 13 demonstrated that early pulse oximetry screening for home births is both feasible and acceptable among midwives in Birmingham.
A meta-analysis of pulse oximetry screening reported a sensitivity of 79.5% (95% CI 70.0-86.6) for studies that performed screening prior to 24 hours and a sensitivity of 73.6% (95% CI 62.8-82.1) for studies that performed screening after 24 hours. 9 The advantage of early testing is that it enables the timely diagnosis of conditions for which early intervention is paramount to achieving good outcomes.
The survival of infants with d-loop transposition of the great arteries and an intact ventricular septum may depend on timely access to cardiac services capable of performing a balloon arterial septostomy. 14 The infants in this study with confirmed CCHD were screened at an age of 2, 6 and 7 hours, respectively, which enabled early diagnosis and immediate intervention.
The benefits of an early screening strategy should be weighed against the harm that may come from low saturation readings in the context of transitional circulation. In comparison with late screening strategies, early screening has been shown to carry a higher false-positive burden. 15, 16 Limiting the number of positive results unrelated to cardiac disease has been a key consideration for those electing to initiate screening >24 hours after birth. 17 It has been reported that 4%-5% of infants screened on day one of life will require repeat testing in order to exclude healthy infants with transitional circulation. 12, 17 In this study, the lowest rate of positive results unrelated to pathology was indeed observed after 24 hours.
The yield from pulse oximetry screening does, however, appear to be inversely related to time. In this study, one pathology was identified for every 245 tests that were performed <4 hours after birth compared with one pathology for every 309 tests performed between 4 and 12 hours. One pathology was identified among the 6197 tested after 12 hours. Early pulse oximetry screening therefore improves the likelihood of identifying disease before the onset of symptoms.
The anxiety and inconvenience caused by false-positive or inconclusive test results will likely be greatest in those based in rural areas where access to specialist services is limited. Two infants in this study found to have low saturation levels travelled 80 km for an assessment. Both babies were screened at an early age and had normal oxygen saturations by the time they reached the referral centre. It is a challenging task to design a screening algorithm that will limit the number of false-positive results yet also enable the timely diagnosis of infants with critical cardiac disease. This is especially so for those living in remote areas where a specialised paediatric assessment is not readily available. infants as this would not have provided evidence to support the design of a screening strategy best suited for such an environment in which the time frame for offering screening may be very limited. It is reassuring that screening during breastfeeding was not different from screening awake and settled babies demonstrating that screening does not have to interfere with the bonding between a mother and her infant.
As single-limb screening strategy was used in this study. The simplicity of performing the test on one limb was an important consideration as significant concerns were raised about the impact of the test on the workload of midwives. The Cochrane systematic review found no difference in sensitivity or specificity for pulse oximetry screening between post-ductal screening alone and preductal and post-ductal screening. 9 Therefore, to optimise uptake and decrease workload, a decision was made that post-ductal screening was most appropriate in this setting.
Several studies have reported that more than two-thirds of positive screening results will yield a diagnosis other than cardiac disease. [18] [19] [20] The broader value of this screening test is highlighted in this study where 33 out of 48 (69%) infants with a positive screening result had a respiratory or infectious disease. This is of particular significance to communities with a high antenatal detection rate of cardiac disease where the yield from pulse oximetry screening for such anomalies will be lower.
| CON CLUS ION
In a maternity setting where length of admission is often measured in hours rather than days, adopting an early pulse oximetry screening strategy is unavoidable. This is associated with low oxygen saturation recordings in association with a wide range of disease. As the term suggests, pulse oximeters identify an abnormal heart rate and low oxygen saturation levels regardless of what the underlying cause may be. The utility of the device therefore stretches beyond identifying congenital cardiac disease in the newborn population where it is challenging to detect cyanosis clinically. This study clearly demonstrates that pulse oximetry screening is a valuable test even in the context of a high antenatal detection rate for cardiac anomalies. The number of positive test results in infants with no underlying disease can be limited if the test is performed beyond 4 hours of age on an infant that is either breastfeeding or settled, but awake.
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